Credits: Canva
Until law, GLP-1 drugs were used to treat diabetes, obesity and even the recent evidences suggest that it could as well be used to treat chronic kidney problems. There is yet another research, published in JAMA Psychiatry on February 25, titled Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial that explores if GLP-1 receptor agonist semaglutide reduce alcohol consumption and cravings in adults with alcohol use disorder.
The research was conducted over a period of 9 weeks, where in the randomized clinical trial, the participants who were administered semaglutide, it led to reductions in some but not all measures of weekly consumptions. It also reduced weekly alcohol and craving related to placebo, and also led to a greater relative reduction in cigarettes per day.
The research also found that weekly injections of semaglutide, which is the active ingredient in weight loss drugs like Wegovy also helped reduce cravings in people with alcohol use disorder.
The lead author Christian Hendershot said that these findings will help in developing new approaches to treat alcoholism. "Two drugs currently approved to reduce alcohol consumption aren't widely used. The popularity of Ozempic and other GLP-1 receptor agonists increases the chances of broad adoption of these treatments for alcohol use disorder," said Hendershot in news release by the University of Southern California's Institute for Addiction Research, where he is the director.
The study is government-funded research and was funded by the National Institute on Alcohol Abuse and Alcoholism, part of the National Institutes of Health.
The study was small, and took in account for only 48 adults over two months, thus experts say that it is not yet clear how safe these drugs are for people who do not need to lose weight. Though the results do add up with the evidence form animal studies on drugs like Ozempic and Wegovy on how it helps manage cravings, not just for food, but also for tobacco and alcohol. Scientists are also studying these drugs on smokers, people with opioid addiction and cocaine users.
Co-author Dr Klara Klein of the University of North Carolina at Chapel Hill who treats people with obesity and diabetes said, "This is such promising data. And we need more of it. We frequently will hear that once people start these medications that their desire to drink is very reduced, if not completely abolished."
The GLP-1 receptor agonists work by mimicking hormones GLP-1 in the gut and brain that regulates appetite and feelings of fullness. This response is what helps one lose weight, and what helps one curb their craving for alcohol. These drugs that mimic the functioning of your brain, which is responsible to tell your body when to stop consuming, are the same hormones that tell your body about other kinds of consumptions, including alcohol. Therefore by consuming the weight loss drugs one can treat alcohol use disorder.
However, the researchers have pointed out on the limited data on the research and have suggested to continue using the three approved drugs by the National Institute on Alcohol Abuse and Alcoholism and Substance Abuse and Mental Health Services Administration, namely, Disulfiram, Naltrexone, and Acamprosate to treat alcohol use disorder until large studies confirm these findings.
Nasal sprays must not be used more than five times a week. (Photo credit: AI generated)
In an ever-evolving world, people are always looking for something more convenient. Thanks to this never-ending search for an easier way out, even the ways of using medicine have changed. From popping pills to now using nasal sprays for decongestion, the way we deal with a cold or the flu has also changed. But just like all other aspects of life, one must know where to stop. Unsurprisingly, cases of nasal spray addiction have come to light, and the consequences are not pretty.
In the UK, the Medicines and Healthcare products Regulatory Agency (MHRA) has stated that excessive use of nasal spray can lead to ‘rebound congestion’ and other major side effects. While people were mindlessly using nasal sprays for seven days in a row, a new advisory limits use to just five days. Brits are reportedly becoming addicted to nasal sprays because of excessive use to relieve blocked noses, thereby causing damage to the tissues inside.
Decongestant sprays constrict inflamed blood vessels in the nasal passages, thereby relieving congestion. In the short term, they work well. However, if used too much, the blood vessels in the nasal passages become sensitive to ingredients like xylometazoline and oxymetazoline. These passageways also start to swell when the medication wears off. In the long run, addiction or overuse of nasal sprays can lead to the following symptoms:
In an interview with Health and Me, Dr Samir Garde, Director of the Department of Pulmonology and Lung Transplant at Gleneagles Hospital, Parel, said, “Many people have a habit of using nasal sprays mindlessly. So, even though they tend to provide that much-needed relief, they can take a toll on well-being. Using nasal sprays too often, particularly decongestant sprays, can do more harm than good. While they give quick relief from a blocked nose, overuse can lead to a problem called rebound congestion. This happens when the nose becomes even more blocked once the effect wears off. This can make people dependent on the spray and even cause addiction. Moreover, excessive use also dries out the nasal lining, causing irritation, burning, or even small nosebleeds.”
Some people may experience headaches or a constant feeling of stuffiness that can disturb peace of mind and interfere with daily routine. In the long run, it can damage the sensitive tissues inside the nose and reduce the spray’s effectiveness. So, use nasal sprays strictly as per a doctor’s advice. Do not overdo it. Anything done in excess can be harmful to health. Take charge of your wellbeing and follow medical advice carefully.
Credit: AI generated image
In a bid to ensure safe healthcare environments, India's Ministry of Health and Family Welfare (MoHFW) has launched a nationwide Fire Safety Week across healthcare facilities.
The Fire Safety Week will be observed from May 4 to May 10 across the country. The theme of this year’s Fire Safety Week is “Safe Schools, Safe Hospitals, and a Fire-Safety Aware Society: Together for Fire Prevention”.
Fire safety in healthcare facilities is a critical component of patient safety and health system resilience. Hospitals house vulnerable patients, high electrical loads, oxygen-rich environments, and complex medical equipment, making them particularly susceptible to fire hazards.
"Fire Safety Week provides an important opportunity to reassess existing infrastructure, evaluate whether facilities have been adequately audited, and identify gaps and discrepancies that need to be addressed," said Union Health Secretary, Punya Salila Srivastava, while launching the initiative.
Emphasizing capacity building, she stressed that healthcare professionals must be adequately trained and sensitized to effectively respond to fire emergencies.
The nationwide campaign is designed to go beyond awareness and focus on actionable preparedness. States and healthcare institutions will:

Recognizing the increasing need to strengthen preparedness and ensure continuity of healthcare services during emergencies, the Health Ministry has also developed the National Guidelines on Fire and Life Safety in Healthcare Facilities (2026). This is a revised version of the Fire and Life Safety Guideline (2020).
The primary objective of the guidelines is to provide a standardized and practical framework to strengthen fire prevention and response mechanisms in healthcare facilities. Key features of the revised guidelines include:

These guidelines are expected to:
Credit: AI generated image
Amid rising obesity, early diabetes risk, and mental health issues among children, India has expanded its child health screening program to include behavioral disorders and non-communicable disease (NCD) risk factors.
The Ministry of Health and Family Welfare rolled out the screening measures under the revised Rashtriya Bal Swasthya Karyakram (RBSK) 2.0 guidelines.
The guidelines include steps to address mental health conditions and early risk factors for diseases such as diabetes and hypertension. These were released at the recently concluded National Summit on Good Practices and Innovations in Public Healthcare Service Delivery.
The screening services are free and will be delivered through mobile health teams at Anganwadi centers and schools, ensuring universal outreach and early identification.

Children with Type 1 Diabetes Mellitus can develop diabetic ketoacidosis (DKA) if it is not diagnosed on time, since they are insulin-dependent.
Dr. Archana Arya, Senior Consultant Pediatric & Adolescent Endocrinologist at the Institute of Child Health, Sir Ganga Ram Hospital, New Delhi, told HealthandMe that DKA requires hospitalization for treatment, and if undiagnosed, it can lead to coma and death. Early diagnosis reduces morbidity and hospital admissions.
These children present with typical symptoms such as
Type 2 Diabetes Mellitus may or may not present with typical symptoms, and children may develop long-term complications such as retinopathy and nephropathy if the condition goes undiagnosed for a prolonged period.
All overweight and obese children, especially those with a family history of Type 2 diabetes, those with acanthosis nigricans (thickened and dark skin behind the neck and underarms), and girls with PCOS are at high risk of developing Type 2 diabetes and should be screened annually to prevent complications.
The expert added that children with diabetes are at a higher risk of depression (2–3 times higher prevalence), anxiety, and suicidal ideation (in 8–27 percent of youth) due to dietary restrictions and the burden of multiple insulin injections in Type 1 diabetes. Diabetic youth are 1.7 times more likely to attempt suicide, often through insulin overdose.
Dr. Seema Dhir, Unit Head & Senior Consultant, Internal Medicine, Artemis Hospitals, told HealthandMe that good health in early life is essential for preventing non-communicable diseases such as obesity, diabetes, and heart disease. Diabetes is often linked to poor lifestyle and health choices.
Early monitoring, detection, and effective management can reduce the growing burden of diabetes.
Dr. Munia Bhattacharya, Senior Consultant – Clinical Psychology, Mental Health and Behavioural Sciences, Marengo Asia Hospitals, Gurugram, emphasized that preventing non-communicable diseases like diabetes, heart disease, and obesity begins with maintaining both mental and physical well-being.
Providing mental support to children helps them cope better with stress and reduces the risk of anxiety, depression, and suicidal thoughts.
Children who are encouraged to express their feelings and seek help are less likely to experience anxiety, depression, and suicidal tendencies. Early awareness also builds coping skills, decision-making abilities, and healthier lifestyles—paving the way for long-term well-being and a more balanced, confident future.
© 2024 Bennett, Coleman & Company Limited